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Abstract
Introduction: Oxidative stress has been reported to be involved in numerous human diseases, including musculoskeletal
disorders such as osteoarthritis. However, the interaction between intervertebral disc (IVD) degeneration and oxidative
stress is not well understood. The purpose of the present study was to elucidate the contribution of oxidative stress to
IVD degeneration and the efficacy of antioxidant treatment for degenerative discs.
Methods: The expression level of an oxidative stress marker, nitrotyrosine, was assessed by immunohistochemistry and
Western blotting. For evaluating intracellular reactive oxygen species (ROS) levels and oxidative stress in rat annulus
fibrosus (AF) cells, flow cytometry and luciferase assay with an OKD48 construct were performed. The grade of IVD
degeneration was assessed by magnetic resonance imaging and histological analysis.
Results: A high frequency of nitrotyrosine-positive cells was observed in rat and human degenerative discs. mRNA
expression of catabolic factors such as tumor necrosis factor-alpha (TNF-alpha), matrix metalloprotease-3 (MMP-3), and
cyclooxygenase-2 (COX-2) was significantly induced by treatment with H2O2 or buthionine sulfoximine, whereas that of
aggrecan, an important chondrogenic proteoglycan, was reduced in a dose-dependent manner. Treatment with
mitogen-activated protein kinase (MAPK) inhibitors blocked the inductive effect of excessive ROS on COX-2
mRNA expression. Western blotting confirmed the phosphorylation of MAPKs in H2O2 and BSO-treated AF cells.
Conversely, we showed that TNF-α induced oxidative stress with increased intracellular ROS levels in AF cells. Treatment
with the antioxidant N-acetyl cysteine (NAC) abrogated the catabolic effect of excessive ROS and TNF-alpha in vitro.
Finally, we showed that oral administration of NAC prevented IVD degeneration in rat degenerative model.
Conclusions: A positive feedback loop was formed between excessive ROS and TNF-alpha in AF cells. Thus, oxidative
stress contributes to the progression of IVD degeneration and NAC can be a therapeutic option for IVD degeneration.
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Introduction
Intervertebral disc (IVD) degeneration is clinically re-
lated to chronic low back pain, disc herniation, spinal
canal stenosis, and spinal deformities [1]. These spinal
disorders are the leading causes of disability in the work-
force and result in large economic and social costs [2].
The etiology of IVD degeneration is complex and multi-
factorial, with contributions from aging, mechanical
stress, smoking, infection, trauma, and heredity [3–5].
At present, the molecular mechanisms underlying IVD
degeneration are largely unclear, and there are no
effective therapies.
IVDs, which lie between the adjacent vertebral bodies
and provide flexibility and load support in the spine, are
composed of two discrete components: the nucleus pul-
posus (NP) and the annulus fibrosus (AF). The interior
structure, the NP, is an avascular cartilage-like tissue that
contains extracellular matrix (ECM) proteins rich in
proteoglycans. The AF, a fibrous cartilage composed of
an inner and outer coaxial lamella, enwraps the NP. The
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NP has two different cell populations in humans: small
chondrocyte-like cells and large vacuolated notochordal
cells [6–8]. Because notochordal cells are rarely present
after adolescence, the pathogenesis of IVD degeneration
is possibly linked to loss of the cells [6, 9].
IVD degeneration is characterized by the reduction of
water content and ECM breakdown. Biologically, this
degeneration represents a loss of steady-state metabol-
ism that probably results from an imbalance between
anabolic and catabolic processes [10, 11]. Increased ex-
pression of proinflammatory cytokines such as interleu-
kin (IL)-1 and tumor necrosis factor alpha (TNFα) and
loss of aggrecan, a major component of proteoglycan in
IVD, have been observed in degenerative discs [12, 13].
These changes are associated with the increased expres-
sion of matrix-degrading enzymes such as matrix metallo-
proteases (MMPs) and a disintegrin and metalloprotease
with thrombospondin motifs (ADAMTS) [14–17]. Many
studies have found elevated levels of MMP-1, MMP-2,
MMP-3, and MMP-13 in degenerated IVD [14, 15]. In
addition, several lines of evidence support the presence of
prostaglandins in IVD under stress and implicate the
possible involvement of prostaglandins in the progres-
sion of IVD degeneration [18, 19]. The expression of
cyclooxygenase-2 (COX-2), a key enzyme in prostaglan-
din biosynthesis in disc cells, has also been shown to be
induced by mechanical stress, another predisposing fac-
tor that can disrupt the disc structure and initiate the
degenerative cascade [20, 21]. These inflammatory re-
actions are clinically known to be the cause of lower
back pain or radiculopathy in spinal disorders [22].
According to the free-radical theory of aging, oxidative
stress initiated by reactive oxygen species (ROS) contrib-
utes to the functional decline that is characteristic of
aging [23]. ROS, including the superoxide anion (O2−),
the hydroxyl radical (OH), hydrogen peroxide (H2O2),
and nitric oxide (NO), all of which can diffuse through
membranes, are byproducts of cellular oxidative metab-
olism. Excessive ROS can overwhelm the antioxidant
scavenging capacity within a cell and cause oxidative
damage to DNA, lipids, and proteins as well as concomi-
tant cellular damage. Numerous diseases are known to
involve oxidative stress, including musculoskeletal dis-
eases such as osteoarthritis and osteoporosis [24–26]. In
IVD, the expression level of similar oxidative stress
markers such as carboxymethyl-lysine, advanced glyca-
tion end products (AGEs), and peroxynitrite were
reported to be elevated in degenerative human discs
[27–29]. In cultured disc cells, the activation of p38
mitogen-activated protein kinase (MAPK), extracellular
signal-regulated kinase (ERK), c-Jun N-terminal kinase
(JNK), and Akt signaling pathways and nuclear trans-
location of nuclear factor (NF)-κB and Nrf2 were re-
ported to be induced by treatment with H2O2 [30]. In
vivo, the mitochondria-targeted ROS scavenger rescued
age-related disc degeneration in the murine model [31].
However, the interaction between IVD degeneration and
oxidative stress induced by excessive ROS is not yet
completely understood. The primary objective of this
study was to clarify the role of excessive ROS in the
catabolic cascade of degenerative IVD. The secondary
goal was to determine whether excessive ROS represents
a therapeutic target for IVD degeneration. We clearly
demonstrated that oxidative stress contributes to IVD
degeneration and that antioxidant treatment rescues the
phenotype of the IVD degeneration model. These results
indicate that excessive ROS plays an important role in
the pathogenesis of disc disease and can offer a therapeutic




For the experimental use of surgical samples, written in-
formed consent was obtained from each patient accord-
ing to the Keio University (Tokyo, Japan) Hospital Ethics
Guideline (Keio Hospital #15-52). A total of 10 IVD tis-
sues were dissected from patients with degenerative dis-
ease, including eight with degenerative lumbar scoliosis,
one with degenerative lumbar kyphosis, and one with
adult idiopathic scoliosis. They were evaluated according
to Pfirrmann’s magnetic resonance classification
(Table 1). As a nondegenerative disc, 17-year-old male
IVD dissected at autopsy was used. They were fixed in
4 % paraformaldehyde in phosphate-buffered saline and
embedded in paraffin to obtain sections 4 μm thick.
Animal model of IVD degeneration
All animals were purchased from Japan Clea (Tokyo,
Japan) or born and kept under pathogen-free conditions
and were cared for in accordance with the guidelines of
the Keio University School of Medicine. Posterior inci-
sion above the coccyx IVD of 8-week-old female Wistar
rats was made, and the soft tissues such as posterior ten-
dons and ligaments were separated under anesthesia.
Disc puncture was performed using a 23-gauge needle
on the 3rd–10th coccygeal vertebrae, as in a previous
study [32, 33]. For analysis, a total of 27 rats were sacri-
ficed. A total of nine IVDs were used in each group. For
real-time RT-PCR analysis, AF tissues were dissected
through a microscope and homogenized only once
1 week after the puncture. The total RNA of the homog-
enized AF was extracted using TRIzol Reagent (Cosmo
Bio Company, Tokyo, Japan). For western blotting, the
protein of AF tissues was extracted using Tissue Protein
Extraction Reagent (TPER) 1 month after puncture.
Magnetic resonance imaging (MRI) was performed
2 months after the puncture. After that, AF tissues were
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dissected for histological analysis. The harvested discs
were decalcified and embedded in paraffin, and sections
4 μm thick were cut. To assess the effect of antioxidant
treatment, N-acetyl cysteine (NAC, 1 g/l; Sigma-Aldrich,
St. Louis, MO, USA) was given orally to degenerative
model rats 1 week before puncture and continued for
another 2 months until MRI and histological analysis.
Imaging
Mid-sagittal T2-weighted MRI (TR/TE, 3000/86; echo
train length, 12; slice thickness, 2 mm; field of view,
10 cm; matrix size, 352 × 224; number of excitations, 10
times) (GE Sigma Excite HD 1.5 T; GE Healthcare,
Tokyo, Japan) of rat IVD was performed. The ratio of
the high-intensity area to IVD was measured using
Image Processing and Analysis in Java (Oracle Corpor-
ation, Redwood Shores, CA, USA).
Histology
Deparaffinized sections of rat IVD were stained with
hematoxylin and eosin (H&E). The sections were stained
with anti-nitrotyrosine antibody (diluted 100-fold; Abcam,
Cambridge, UK), followed by staining with horseradish
peroxidase (HRP)-conjugated goat antimouse IgG (diluted
200-fold; Sigma-Aldrich), anti-TNFα antibody (diluted
100-fold; Novus Biologicals, Littleton, CO, USA), and anti-
IL-1β (diluted 100-fold; Bioworld Technology, St. Louis
Park, MN, USA), followed by HRP-conjugated goat anti-
rabbit IgG (diluted 200-fold; Sigma-Aldrich). Staining was
visualized using diamino benzidine (nacalai tesque, Kyoto,
Japan). Nuclei were stained with hematoxylin. Antigen re-
trieval was achieved by pressure-cooking in citrate buffer
(pH 6.0) for 20 minutes. All specimens were viewed under
a microscope (BZ-9000; Keyence Co., Osaka, Japan). The
frequency of nitrotyrosine-positive cells was measured
using Image Processing and Analysis in Java at a magnifi-
cation of × 200. We chose three individual areas at random
and calculated the average of the frequency.
Isolation and culture of AF cells
Rat AF tissues were macroscopically dissected from the
lumbar and coccyx IVD of 8-week-old female Wistar
rats and digested using pronase E (0.04 %) (SERVA,
Heidelberg, Germany) for 1 hour at 37 °C and collage-
nase P (0.025 %) (Roche Diagnosis, Tokyo, Japan) for
4 hours at 37 °C. The cells were then washed with
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen,
Carlsbad, CA, USA) containing 5 % heat-inactivated fetal
bovine serum (FBS; JRH Biosciences, Lenexa, KS, USA)
according to a previous method [34]. The isolated AF cells
were cultured in DMEM supplemented with 10 % FBS
and 1 % penicillin–streptomycin, maintained in a humidi-
fied incubator containing 5 % CO2 at 37 °C, and used
within the first five passages for in vitro analysis. We have
confirmed there was no obvious difference in the mRNA
expression level of important ECM of AF cells, type I col-
lagen, type II collagen, and aggrecan between the second
and fifth passaged cells (Additional file 1: Figure S1).
Treatment of oxidative stress, TNFα, MAPK inhibitors, and
antioxidants
AF cells were treated with H2O2 (0, 10, 100 μM) (Wako,
Tokyo, Japan), buthionine sulfoximine (BSO; 0, 0.2,
1 mM) (Sigma-Aldrich), and TNFα (50 ng/ml) (R&D
Systems, Minneapolis, MN, USA) for 24 hours. For ana-
lysis of phosphorylation, AF cells were treated with
100 μM H2O2 for 0, 5, 10, 15, 30, or 60 minutes and
50 ng/ml TNFα for 10 minutes. Cells were pretreated
with MAPK signaling inhibitors for 30 minutes followed
by incubation with H2O2 or BSO for 24 hours. In this
assay, we utilized p38 inhibitor (SB203580, 10 μmol/l),
JNK inhibitor (SP600125, 10 μmol/l), or ERK inhibitor
(PD98059, 10 μmol/l). All inhibitors were purchased
from Wako. To study the effect of antioxidative agents,
H2O2-treated, BSO-treated, or TNFα-treated AF cells
were cultured with 100 μM NAC and 20 mM α-
tocopherol (Wako) solved in ethanol for 15 minutes,
Table 1 Patient details used for the experiments
Sample number Sex Age (years) Level Gradinga Diagnosis
1 Female 32 L1/2 3 Adult idiopathic scoliosis
2 Male 55 L2/3 3 Degenerative lumber scoliosis
3 Male 55 L3/4 3 Degenerative lumber scoliosis
4 Female 53 L3/4 3 Degenerative lumber scoliosis
5 Female 53 L2/3 4 Degenerative lumber scoliosis
6 Female 75 L1/2 4 Degenerative lumber scoliosis
7 Female 75 L2/3 4 Degenerative lumber scoliosis
8 Female 75 L3/4 5 Degenerative lumber scoliosis
9 Female 75 L4/5 5 Degenerative lumber scoliosis
10 Male 77 L2/3 5 Degenerative lumber kyphosis
aPfirrmann disc degeneration grading
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30 minutes, or 24 hours. In the case of α-tocopherol ex-
periment, ethanol was added at the same concentration
to ROS-mediated or TNFα-treated AF cells. The experi-
ment of α-tocopherol treatment was independently car-
ried out five times, and all other experiments were
independently carried out three times.
Real-time RT-PCR
Total RNA was isolated from AF cells using the RNeasy
Mini Kit (Qiagen GmbH, Hilden, Germany) or TRIzol
Reagent. First-strand cDNA was prepared using the Prime
Script RT Reagent Kit (Takara Bio, Shiga, Japan) according
to the manufacturer’s instructions. Real-time RT-PCR was
performed using the Thermal Cycler Dice Real-Time Sys-
tem and SYBR Premix Ex Taq (Takara Bio), and the results
were quantified using the ddCt method. We measured the
relative mRNA expression of TNFα, MMP-3, COX-2, and
aggrecan normalized by the expression of β-actin or hypo-
xanthine phosphoribosyl transferase (HPRT). Gene-specific

















3′; and Col2a1-reverse, 5′-GCCCTATGTCCACAC-
CAAATTC-3′.
Intracellular ROS
The dissociated cells were loaded with Mitotracker Or-
ange CMH2TM ROS (Life Technologies, Carlsbad, CA,
USA) and incubated on a shaker at 37 °C for 30 minutes.
For the estimation of intracellular ROS, a FACS Calibur
was used (Becton-Dickinson Immunocytometry Systems,
San Jose, CA, USA).
Western blotting
Total cell protein was extracted using a mammalian
protein extraction reagent (Thermo Fisher Scieintific,
Waltham, MA, USA). All of the wash buffers and ex-
traction buffers included 1× protease inhibitor cocktail
(Roche), NaF (1 M), and Na3VO4 (50 μM). Cell lysates
mixed with loading buffer (Tris–Glycine SDS Sample
Buffer (Invitrogen) with 5 % 2-mercaptoethanol)
were loaded onto 15 % polyacrylamide gels and electro-
phoresed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. Proteins were transferred to polyvinyli-
denefluoride membranes (ATTO Corporation, Tokyo,
Japan). The membranes were blocked using 5 % nonfat
dry milk in Tris-buffered saline containing 0.1 % Triton
X-100 (TBST) (50 mM Tris, pH 7.6, 150 mM NaCl,
0.1 % Tween 20) and incubated overnight at 4 °C in 3 %
nonfat dry milk in TBST with antibody against p38
(1:1000; Cell Signaling Technology, Boston, MA, USA),
phosphorylated p38 (1:1000; Cell Signaling Technology),
ERK (1:1000; Cell Signaling Technology), phosphory-
lated ERK (1:2000; Cell Signaling Technology), JNK
(1:1000; Cell Signaling Technology), phosphorylated JNK
(1:1000; Cell Signaling Technology), NF-κB p65 (1:1000;
Cell Signaling Technology), phosphorylated NF-κB
p65, and β-actin (1:1000; Cell Signaling Technology),
followed by HRP-conjugated goat antirabbit IgG (1:2000;
Sigma-Aldrich). Proteins were visualized using ECL
Western Blotting Detection Reagent (GE Healthcare,
Uppsala, Sweden).
Transfections and dual luciferase assay
Cells were transferred to 24-well plates at a density of
5 × 104 cells/well 1 day before transfection. LipofectA-
MINE 3000 (Invitrogen) was used as the transfection re-
agent. The experiment was performed following the
manufacturer’s recommendation. The optimized ratio of
plasmids and posttransfection period were determined
in previous reports [35]. Cells were cotransfected with
300 ng GL4-F (OKD48) with 200 ng pRL-TK plasmid.
Plasmids were premixed with the transfection reagent
for each transfection. Transfected cells were harvested
the next day, and the Dual-Luciferase Reporter Assay
System (Promega, Madison, WI, USA) was used for se-
quential measurements of firefly and Renilla luciferase
activities. Luciferase activities were quantified, and rela-
tive ratios were calculated using a luminometer (TD-20/
20; Turner Designs, Sunnyvale, CA, USA). Three inde-
pendent transfections were performed, and all analyses
were carried out in triplicate.
Plasmids
P(3 × ARE)TKbasal-hNrf2(1–433)-GL4-F (OKD48) was
provided by Dr Takao Iwawaki, Gunma University [36].
The vector pRL-TK (Promega) harboring the Renilla
reniformis luciferase gene was used as an internal trans-
fection control.
Statistical analysis
All measurements were performed in triplicate. Data are
presented as mean ± standard deviation (SD). Differences
between the groups were analyzed by Student’s t test











































































































































































































































































*Pfirrmann disc degeneration grading
* Grade 3 (53 y/o) * Grade 4 (53 y/o)
*
Fig. 1 (See legend on next page.)
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and analysis of variance (ANOVA). p <0.05 was consid-
ered to indicate statistical significance.
Results
Induction of ROS level in IVD degeneration
To investigate the involvement of ROS in IVD degener-
ation, we first assessed one of the oxidative stress markers,
nitrotyrosine, in a rat punctured model and in human de-
generative IVD samples. A total of nine discs per group
were used for the analysis. Mid-sagittal T2-weighted MRI
findings of IVD in the rat punctured model confirmed a
lower signal intensity than that in the sham group (Fig. 1a).
The ratio of the high-intensity area to IVD was signifi-
cantly reduced in the model (Fig. 1b). H&E staining
showed a smaller NP and less-organized lamellae of AF in
the punctured model (Fig. 1c). In addition, we confirmed
that the mRNA expression of TNFα, MMP-3, and COX-
2—catabolic molecules involved in degeneration—was
significantly induced in AF of the punctured model,
whereas that of aggrecan tended to be reduced, but not
significantly (Fig. 1d). These results suggest that the needle
punctured model is adequate for analysis of IVD degener-
ation. The expression of nitrotyrosine as well as TNFα and
IL-1β was higher in AF of this model group compared
with that of the sham group (Fig. 1e). Western blotting
also showed a higher protein expression level of nitrotyro-
sine as well as TNFα and IL-1β in the rat degenerative
model (Fig. 1f). Densitometry analysis confirmed these ob-
servations (Fig. 1f). Moreover, immunohistochemistry
showed that human degenerative disc samples with each
grade had a high proportion of nitrotyrosine-positive cells,
accompanied by robust expression of TNFα and IL-1β,
whereas human healthy disc had low expression of these
markers (Fig. 1g). We assessed the frequency of
nitrotyrosine-positive cells in each grade sample. Figure 1h
showed that more than grade 3 degenerative discs had a
significantly higher frequency of nitrotyrosine-positive
cells compared with healthy disc (Fig. 1h).
Molecular phenotype of the rat AF cells treated with ROS
To clarify the pathophysiological role of intracellular
ROS, we examined the phenotype of the AF cells treated
with H2O2 and BSO, which is a glutathione synthesis
inhibitor that activates oxidative stress. Flow cytometry
confirmed that the intracellular level of ROS was signifi-
cantly increased by treatment with both H2O2 and BSO
in AF cells (Fig. 2a). Next, we treated rat cultured AF
cells with H2O2 and evaluated the expression of cata-
bolic and anabolic factors of IVD degeneration by real-
time RT-PCR analysis. We found that the mRNA
expression of TNFα, MMP-3, and COX-2 was signifi-
cantly induced, whereas that of aggrecan was reduced in
a dose-dependent manner (Fig. 2b). Expectedly, real-
time RT-PCR showed similar results with BSO treatment
(Fig. 2c). To investigate the downstream signaling of
ROS in AF cells, we evaluated the phosphorylation of
MAPKs, including p38, ERK, and JNK, as well as p65 by
western blotting. This analysis showed that the three sig-
naling pathways of MAPK were maximally phosphory-
lated 10 minutes after treatment with H2O2 and BSO
(Fig. 3a, b). On the other hand, the phosphorylation of
p65 was not activated by their treatments (Fig. 3a, b).
Next, to investigate further the involvement of MAPKs,
we cultured H2O2-treated or BSO-treated AF cells with
MAPK signaling inhibitors, including p38 inhibitor
(SB203580), JNK inhibitor (SP600125), and ERK inhibi-
tor (PD98059), and assessed the mRNA expression of
COX-2, TNFα, and MMP-3 by real time RT-PCR ana-
lysis. Figure 3c, d shows that all inhibitors significantly
abolished H2O2-mediated or BSO-mediated induction of
COX-2 mRNA expression. These results suggest that the
catabolic effect of excessive ROS is mediated through
the signaling pathways of p38, ERK, and JNK in AF cells.
However, the results of TNFα and MMP-3 did not
clearly show the effect of these inhibitors compared with
COX-2 (Additional file 2: Figure S2). The gene regula-
tory network of TNFα and MMP3 can be more compli-
cated than that of COX-2. The experiment concerned
with the mechanisms of the difference is in progress.
Antioxidant significantly neutralized the catabolic effect
of ROS
Next, to ascertain whether the treatment of antioxidant
attenuates the ROS-mediated catabolic effect in AF cells,
we treated AF cells with NAC, together with H2O2 or
BSO. Using real-time RT-PCR analysis, we found that
(See figure on previous page.)
Fig. 1 Induction of ROS level in IVD degeneration. a Mid-sagittal T2-weighted MRI findings of IVDs 2 months after the puncture confirm lower signal
intensity than that of the sham group. b Compared with the sham group, the ratio of the high-intensity area to IVD areas was significantly decreased
by needle puncture. c Hematoxylin and eosin (H/E) staining shows smaller NP and less-organized lamellae of AF in the punctured group. Scale bars,
300 μm. d Real-time RT-PCR analysis. mRNA expression of TNFα, MMP-3, and COX-2 was significantly induced in the AF of the punctured model,
whereas that of aggrecan tended to be reduced. Data presented as mean ± SD of three independent experiments performed in triplicate (n = 3).
e Numbers of nitrotyrosine-positive cells were increased in AF of the punctured model, correlated with elevated expression of TNFα and IL-1β. Scale
bars, 100 μm. f Western blotting and densitometry analysis. The protein expression level of nitrotyrosine was significantly higher as well as TNFα and
IL-1β in the rat degenerative model. g Immunohistochemistry of human degenerative disc samples with each grade including healthy disc. Scale bars,
100 μm. h More than grade 3 degenerative discs had significantly higher frequency of nitrotyrosine-positive cells compared with healthy disc. *p <0.05.
COX cyclooxygenase, IL interleukin, MMP matrix metalloprotease, ns not significant, TNF tumor necrosis factor
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NAC significantly abolished the induction of TNFα,
MMP-3, and COX-2 expression and reduction of aggre-
can expression in H2O2-treated or BSO-treated AF cells
(Fig. 4a, b). To investigate whether NAC regulates the
downstream signaling of ROS in AF cells, we assessed
the phosphorylation of p38, ERK, and JNK in AF cells
treated with and without NAC. Western blotting and
densitometry analysis clearly showed that treatment with
NAC inhibited the phosphorylation of p38 but not of
JNK, ERK, and p65 (Fig. 4c, d). We also elucidated
whether the other antioxidant material α-tocopherol
(vitamin E) could replicate these effects. As expected,
real-time RT-PCR analysis showed that treatment with
α-tocopherol also abolished the H2O2-mediated or BSO-
mediated change of TNFα, COX-2, MMP-3, and aggre-

















































































































































































































































































































































Fig. 2 Molecular phenotype of the rat AF cells treated with ROS. a Flow cytometry confirmed that the intracellular level of ROS was significantly
increased by treatment with H2O2 and BSO in AF cells. b Real-time RT-PCR analysis showed that the mRNA expression of TNFα, MMP-3, and COX-2 was
significantly induced by treatment with H2O2, whereas aggrecan mRNA expression was reduced in a dose-dependent manner. c mRNA expression of
TNFα, MMP-3, and COX-2 was significantly induced by treatment with BSO, whereas aggrecan mRNA expression was reduced in a dose-dependent
manner, as determined by real-time RT-PCR. Data presented as mean ± SD of three independent experiments performed in triplicate (n = 3); *p <0.05.
BSO buthionine sulfoximine, COX cyclooxygenase, H2O2 hydrogen peroxide, MMP matrix metalloprotease, ns not significant, TNF tumor necrosis factor
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Treatment with antioxidant also significantly inhibited the
effect of TNFα on AF cells
To assess whether intracellular ROS levels are regulated
by inflammatory cytokines in AF cells, we treated cul-
tured AF cells with TNFα and evaluated the level of
intracellular ROS using MitoTracker Orange
CMH2TMR. Flow cytometry showed that ROS levels
were significantly increased in AF cells after treatment
with TNFα (Fig. 6a). Recently, Oikawa et al. [36] re-
ported that an OKD48 construct (P(3 × ARE)TKbasal-
hNrf2(1–433)-GL4-F) specifically responded to oxidative
stress and was useful for monitoring stress in vitro and
in vivo. We transfected the plasmids to AF cells and
assessed the reporter activity with and without TNFα.
As expected, the activity was significantly induced by
treatment with TNFα in AF cells (Fig. 6b). These results
suggest that TNFα upregulates the intracellular ROS
level and induces oxidative stress in AF cells. In addition,
real-time RT-PCR showed that treatment with NAC at-
tenuated TNFα-mediated induction of MMP-3 and
COX-2 expression and reduction of aggrecan in AF cells
(Fig. 6c). In the case of α-tocopherol, significant abolish-
ment of TNFα-mediated induction of MMP-3 and re-
duction of aggrecan was also observed. Concerning
COX-2, α-tocopherol had the tendency to attenuate, but
not significantly, the influence of TNFα (Fig. 6d). More-
over, western blotting clearly showed that NAC treat-
ment inhibited the phosphorylation of p38, ERK, JNK,
and p65 in TNFα-treated AF cells (Fig. 6e). These results
indicated that in AF cells, the catabolic influence of
TNFα was partly mediated by ROS signaling.
Oral administration of NAC improved IVD degeneration in
a rodent model
Finally, to investigate the efficacy of NAC on IVD de-
generation in vivo, we administered NAC (1 g/l) orally
to degenerative model rats 1 week before puncture
and continued for another 1 week until RNA isolation
(n = 9), for 1 month until protein isolation (n = 9), and
for 2 months until MRI analysis and histological
examination (n = 9) (Fig. 7a). Real-time RT-PCR
clearly showed that NAC significantly abolished the
induction of TNFα mRNA expression and reduction
of aggrecan in the AF tissues of the degenerative
model. The mRNA expression of MMP-3 and COX-2
had a tendency to be decreased with oral administra-
tion of NAC in the degenerative model (Fig. 7b). To





























































































































Fig. 3 Downstream signaling of ROS in AF cells. a, b Western blot analysis showed that mitogen-activated protein kinases (MAPKs), including p38,
ERK, and JNK, were maximally phosphorylated 10 minutes after treatment with H2O2a and BSO b. c, d Real-time RT-PCR analysis. Treatment of
AF cells with MAPK signaling inhibitors, including p38 inhibitor (SB), JNK inhibitor (SP), and ERK inhibitor (PD), significantly abolished H2O2-mediated
c or BSO-mediated d induction of COX-2 mRNA expression. Data presented as mean ± SD of three independent experiments performed in triplicate
(n = 3); *p <0.05. BSO buthionine sulfoximine, COX cyclooxygenase, ERK extracellular signal-regulated kinase, H2O2 hydrogen peroxide, HPRT
hypoxanthine phosphoribosyl transferase, JNK c-Jun N-terminal kinase































































































































































































































































































































































































































Fig. 4 (See legend on next page.)
Suzuki et al. Arthritis Research & Therapy  (2015) 17:316 Page 9 of 17
oxidative stress in degenerative discs, we assessed the
protein expression level of nitrotyrosine in AF tissues
1 month after surgery. Western blotting showed that
the expression of nitrotyrosine was clearly reduced by
oral administration of NAC (Fig. 7c). The densitom-
etry confirmed these observations (Fig. 7d). Moreover,
we found that the phosphorylation of p38 was obvi-
ously attenuated by treatment of NAC, but not JNK
and ERK (Fig. 7e). Furthermore, H&E staining showed
improvements in the reduction of NP size and the
disorganization of the AF by oral administration of
NAC (Fig. 7f ). Finally, mid-sagittal T2-weighted MRI
findings showed the maintenance of T2 high intensity
in discs of the degenerative models with NAC (Fig. 7g).
The ratio of the T2-weighted high-intensity area to
IVD was significantly improved by the administration
of NAC in the degenerative group (Fig. 7h).
Discussion
This study demonstrated that excessive ROS, which are
induced in IVD degeneration, have a catabolic effect on
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Fig. 5 Treatment of α-tocopherol significantly abolishes the catabolic effect of ROS. a, b Real-time RT-PCR analysis. Treatment with α-tocopherol
significantly abolished the H2O2-mediated a or BSO-mediated b induction of TNFα and COX-2 mRNA expression, and reduction of aggrecan.
H2O2-mediated induction of MMP-3 expression was not significant, but tended to be decreased. Data presented as mean ± SD of five independent
experiments performed in triplicate (n = 5); *p <0.05. BSO buthionine sulfoximine, COX cyclooxygenase, H2O2 hydrogen peroxide, HPRT hypoxanthine
phosphoribosyl transferase, MMP matrix metalloprotease, ns not significant, TNF tumor necrosis factor
(See figure on previous page.)
Fig. 4 NAC significantly neutralizes the catabolic effect of ROS. a, b NAC significantly abolished the induction of TNFα, MMP-3, and COX-2 expression
and reduction of aggrecan expression in H2O2-treated a or BSO-treated b AF cells by real-time RT-PCR analysis. c, d Western blotting and
densitometry clearly showed that NAC treatment inhibited the phosphorylation of p38 but not of JNK, ERK, and p65. NTC, nontreated control.
Data presented as mean ± SD of three independent experiments performed in triplicate (n = 3); *p <0.05. BSO buthionine sulfoximine, COX
cyclooxygenase, ERK extracellular signal-regulated kinase, H2O2 hydrogen peroxide, JNK c-Jun N-terminal kinase, MMP matrix metalloprotease,
NAC N-acetyl cysteine, ns not significant, TNF tumor necrosis factor







































































































































































































































































































Fig. 6 (See legend on next page.)
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that TNFα induced oxidative stress with increased intra-
cellular ROS levels in AF cells through MAPK and NF-
κB signaling, indicating that a positive feedback loop was
formed between excessive ROS and catabolic factors, in-
cluding TNFα, in IVD degeneration. The second major
observation was that antioxidant NAC significantly abro-
gated the catabolic effect of excessive ROS both in vitro
and in vivo. These findings lend strong support to the
hypothesis that excessive ROS are critical mediators in
the pathogenesis of degenerative disc conditions and are
therapeutic targets for disc diseases.
In this study, we showed that nitrotyrosine, a product
of tyrosine nitration mediated by ROS, was highly
expressed in IVD in a rat degenerative model and in hu-
man degenerative samples. ROS also contribute to the
onset and progression of osteoarthritis by inducing
chondrocyte death and matrix degradation [37].
Tomiyama et al. [38] showed that compression on the
cartilage induced the expression of nitrotyrosine. Fur-
thermore, compared with healthy volunteers, plasma
nitrotyrosine has been reported to be increased in osteo-
arthritis patients [39]. These observations indicated that
nitrotyrosine was useful as an indirect oxidative stress
marker in musculoskeletal degenerative diseases. An
immuno-spin trapping technique which was recently de-
veloped by Khoo et al. [40] can be useful for direct de-
tection of free radicals in future oxidative disc studies.
Many animal models of IVD degeneration have been re-
ported; however, there are few ideal animal models which
precisely mimic a pathological state of human IVD degen-
eration. A rat degenerative model induced by needle punc-
ture has been used in many studies and has been shown
to create morphological and biochemical features similar
to many of those of degenerative discs in humans [41, 42].
Because it is clinically difficult to obtain a sufficient num-
ber of human healthy disc samples, the rat model is help-
ful for comparative study between degenerative and
nondegenerative disc. However, the punctured model still
has some limitations that should be taken into consider-
ation, including the possibility of traumatic changes. We
are assessing the expression level of nitrotyrosine in a rat-
tail static compression-induced disc degeneration model
to clarify the interaction between oxidative stress and
mechanical loading in IVD degeneration.
Clinically, the characteristics of IVD degeneration
such as ECM breakdown can be observed in both the
AF and NP. The NP is known to have small
chondrocyte-like cells and large vacuolated notochordal
cells [6, 7]. Moreover, it has been reported that noto-
chordal cells are rarely present after adolescence in
humans [6]. However, it has not been determined
whether the number of notochordal cells in the NP de-
clines after birth because of their slow transformation
or replacement by chondrocyte-like cells [43]. Which
cells should be clinically targeted for the treatment of
NP degeneration therefore remains unclear. On the
other hand, although AF anatomically consists of inner
and outer layers, the cells existing in both layers are
known to originate from the mesenchyme and are
homogeneous regardless of age and species. Therefore,
it is reasonable to assume that alteration in the molecu-
lar phenotype of AF cells may be directly involved in
IVD degeneration. From these viewpoints, in vitro ana-
lysis of AF cells was carried out to assess disc degener-
ation in this study.
IVD degeneration is characterized by increases in
levels of the proinflammatory cytokines TNFα, IL-1α,
IL-1β, IL-6, and IL-17, secreted by IVD cells [12, 13, 44,
45]. In particular, it is known that TNFα and IL-1β play
pivotal roles in the progression of these degenerative
changes [12, 13]. Cytokines have been shown to upregu-
late chemokines and various catabolic mediators, includ-
ing ADAMTS-4, ADAMTS-5, MMP-1, MMP-2, MMP-3,
MMP-13, and syndecan-4, and to suppress the expression
of important ECM genes through NF-κB and MAPK sig-
naling pathways in degenerative disc cells [14–17, 46, 47].
In a previous study, Yoshimura et al. [48] demonstrated
that IL-1β induced cell death in rat primary chondrocytes
and mouse chondrocytic ATDC5 cells via mitochondrial
dysfunction in a ROS-dependent manner. Our flow cy-
tometry analysis clearly showed that intracellular ROS
levels were significantly induced by treatment with TNFα
in AF cells. Furthermore, to evaluate oxidative stress con-
ditions in TNFα-treated AF cells, a luciferase assay was
carried out using OKD48 construct. Under oxidative stress
conditions, Nrf2, a basic region leucine zipper tran-
scription factor, is known to be stabilized at the post-
transcriptional level [49]. OKD48 consists of an oxidative
(See figure on previous page.)
Fig. 6 Catabolic effect of TNFα is partially mediated by ROS in AF cells. a Flow cytometry showed that ROS levels were significantly increased in
AF cells after treatment with TNFα. b Reporter activity of the OKD48 construct was significantly induced by treatment with TNFα (10 and 50 ng/ml) in
AF cells. c Real-time RT-PCR analysis. Treatment of NAC significantly attenuated TNFα-mediated induction of COX-2 mRNA expression and reduction
of aggrecan in AF cells. Data presented as mean ± SD of three independent experiments performed in triplicate (n = 3). d α-Tocopherol significantly
reduced MMP-3 mRNA expression and restored aggrecan mRNA expression in the TNFα-treated cells. Data presented as mean ± SD of five independent
experiments performed in triplicate (n= 5). eWestern blotting. NAC treatment inhibited the phosphorylation of p38, ERK, JNK, and p65 in TNFα-treated AF
cells. *p <0.05. COX cyclooxygenase, ERK extracellular signal-regulated kinase, HPRT hypoxanthine phosphoribosyl transferase, JNK c-Jun N-terminal kinase,
MMP matrix metalloprotease, NAC N-acetyl cysteine, ns not significant, TNF tumor necrosis factor



















































































































































































































































































Fig. 7 (See legend on next page.)
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stress-inducible promoter, luciferase, and an Nrf2 frag-
ment that contributes to stress-dependent stabilization
[36]. This analysis clearly showed that oxidative stress was
significantly induced by TNFα in AF cells. Vice versa, our
results showed that the expression of catabolic factors, in-
cluding TNFα, was induced by treatment with H2O2 or
BSO in AF cells, which indicated that there was a recipro-
cal interaction between excessive ROS and TNFα in in-
flammatory AF cells (Fig. 8). We previously reported that
ROS activated the ERK and p38 MAPK pathways but not
the JNK pathway in ATDC5 cells [50]. On the other hand,
the present study showed that JNK signaling was also acti-
vated by treatment of AF cells with ROS, suggesting that
the downstream pathway of ROS is cell or tissue specific.
NAC is primarily a pharmaceutical drug for the man-
agement of acetaminophen overdose and is commonly
used as a nutritional supplement. In addition, NAC is
widely used for treatment of lung diseases such as
chronic obstructive pulmonary disease [51, 52]. MRI and
RT-PCR analysis in our in vivo study clearly showed that
the oral administration of NAC prevented the progres-
sion of IVD degeneration. In analysis of molecular
mechanisms, NAC treatment attenuated ROS-mediated
or TNFα-mediated activation of MAPKs, including
ERK1/2, p38, and JNK, and NF-κB signaling in AF cells
in vitro. Previously, resveratrol in red wine and epigallo-
catechin 3-gallate in green tea were also reported to have
an anti-inflammatory and anti-catabolic effect by
modulating the signaling of p38, JNK, or NF-κB in IVD
[53, 54]. Although several human clinical trials with
anticytokine agents have investigated the alleviation of
symptoms of back or radicular pain associated with
IVD degeneration, there are no drugs that can directly
prevent the progression of disc degeneration. Because
the expression of p38 and p65 is ubiquitous, the inhibi-
tors for targeting this signaling are often toxic to normal
cells or tissue and have therefore been clinically unsuc-
cessful [55]. Meanwhile, since NAC is commonly used as
a supplement and has less toxic side effects, it may serve
as a therapeutic option for IVD degeneration. When the
Fig. 8 Schematic of relationship between oxidative stress and disc degeneration. Schematic showing positive catabolic feedback loop between
excessive ROS and catabolic factors in AF cells. Excessive ROS induced expression of catabolic factors, which are upregulated in the degenerative
state, and reduced cartilage ECM aggrecan via the signaling pathways of p38 in AF cells. Conversely, TNFα increased intracellular ROS levels in AF
cells through p38, JNK, ERK, and p65. These pathways were neutralized by NAC. COX cyclooxygenase, ERK extracellular signal-regulated kinase, JNK
c-Jun N-terminal kinase, MAPK mitogen-activated protein kinase, MMP matrix metalloprotease, NAC N-acetyl cysteine, NF nuclear factor, TNF tumor
necrosis factor
(See figure on previous page.)
Fig. 7 Oral NAC administration improves IVD degeneration in the rodent model. a Schematic representation of oral NAC administration experiment
for IVD degenerative model. b Real-time RT-PCR analysis. NAC significantly abolished the induction of TNFα mRNA expression and reduction
of aggrecan in punctured AF tissues. Data presented as mean ± SD of nine IVD discs derived from three independent rats performed in triplicate
(n = 9); *p <0.05. c Western blotting. Protein expression of nitrotyrosine was clearly reduced by oral administration of NAC. d Densitometry confirmed
that the protein level of nitrotyrosine was significantly abrogated by oral administration of NAC. e Western blotting. Phosphorylation of p38
was significantly attenuated by treatment of NAC. f Histological examination of H&E staining showed that oral administration of NAC improved the
reduction of NP size and the disorganization of the AF in this degenerative model. Scale bars, 300 μm. g Mid-sagittal T2-weighted MRI. Area of T2 high
intensity was increased by oral administration of NAC in the degenerative group. Representative data are shown. h The T2-weighted high-intensity area
to IVD ratio was significantly improved by NAC administration. Data presented as mean ± SD; *p <0.05. COX cyclooxygenase, ERK extracellular signal-
regulated kinase, H/E hematoxylin and eosin, JNK c-Jun N-terminal kinase, MMP matrix metalloprotease, MRI magnetic resonance imaging, NAC N-acetyl
cysteine, ns not significant, TNF tumor necrosis factor
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human clinical daily dosage of NAC was converted to rats
normalized with body surface area according to the US
Food and Drug Administration’s guideline, they were al-
most equivalent doses. Experiments are in progress to de-
termine the minimum effective concentration of NAC for
the improvement of IVD degeneration. Recently, clinical
use of another antioxidant, vitamin E, has been established
for the treatment of nonalcoholic steatohepatitis in which
oxidative stress was implicated [56]. Our results showed
that vitamin E also attenuated the ROS-mediated or
TNFα-mediated catabolic effect in the cultured AF cells,
which indicated that vitamin E as well as NAC has the
potential for preventing disc degeneration.
Conclusions
Oxidative stress induced in IVD degeneration has a cata-
bolic effect on AF cells via MAPK signaling. Elevated
TNFα induces oxidative stress with increasing intracellular
ROS levels through MAPK and NF-κB signaling, indicating
that a positive feedback loop is formed between excessive
ROS and TNFα in AF cells. Antioxidant NAC significantly
abrogated the catabolic effect of excessive ROS in vitro and
in vivo. These findings lead strong support for the
hypothesis that NAC can be a therapeutic option for IVD
degeneration.
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Additional file 1: is Figure S1 showing molecular phenotype of the
passaged rat AF cells. Real-time RT-PCR analysis of the mRNA expression
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and fifth (P5) passaged AF cells. Data presented as mean ± SD of three
independent experiments performed in triplicate (n = 3); *p <0.05; ns,
not significant. (PDF 873 kb)
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to AF cells with ROS. Real-time RT-PCR analysis of the expression of TNFα
and MMP-3 in AF cells. MAPK signaling inhibitors, including p38 inhibitor
(SB), JNK inhibitor (SP), and ERK inhibitor (PD), were treated to AF cells
with H2O2 (upper) or BSO (lower). Data presented as mean ± SD of three
independent experiments performed in triplicate (n = 3); *p <0.05; ns, not
significant. (PDF 987 kb)
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